Diabetes 2030: Insights from Yesterday, Today, and Future Trends.

Publisher: Mary Ann Liebert Country of Publication: United States NLM ID: 101481266 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1942-7905 (Electronic) Linking ISSN: 19427891 NLM ISO Abbreviation: Popul Health Manag Subsets: MEDLINE

Original Publication: New Rochelle, NY : Mary Ann Liebert

Diabetes Mellitus, Type 1/*epidemiology ; Diabetes Mellitus, Type 2/*epidemiology; Adult ; Aged ; Centers for Disease Control and Prevention, U.S. ; Databases, Factual ; Diabetes Mellitus, Type 1/economics ; Diabetes Mellitus, Type 1/physiopathology ; Diabetes Mellitus, Type 2/economics ; Diabetes Mellitus, Type 2/physiopathology ; Female ; Geographic Mapping ; Health Care Costs/trends ; Humans ; Male ; Middle Aged ; Morbidity/trends ; Mortality/trends ; Prevalence ; United States/epidemiology ; Young Adult

To forecast future trends in diabetes prevalence, morbidity, and costs in the United States, the Institute for Alternative Futures has updated its diabetes forecasting model and extended its projections to 2030 for the nation, all states, and several metropolitan areas. This paper describes the methodology and data sources for these diabetes forecasts and discusses key implications. In short, diabetes will remain a major health crisis in America, in spite of medical advances and prevention efforts. The prevalence of diabetes (type 2 diabetes and type 1 diabetes) will increase by 54% to more than 54.9 million Americans between 2015 and 2030; annual deaths attributed to diabetes will climb by 38% to 385,800; and total annual medical and societal costs related to diabetes will increase 53% to more than $622 billion by 2030. Improvements in management reducing the annual incidence of morbidities and premature deaths related to diabetes over this time period will result in diabetes patients living longer, but requiring many years of comprehensive management of multiple chronic diseases, resulting in dramatically increased costs. Aggressive population health measures, including increased availability of diabetes prevention programs, could help millions of adults prevent or delay the progression to type 2 diabetes, thereby helping turn around these dire projections.
Competing Interests: Author Disclosure Statement Drs. Rowley and Bezold, and Ms. Arikan, Ms. Byrne, and Ms. Krohe declared the following conflicts of interest with respect to the research, authorship, and/or publication of this article: Dr. Rowley, Dr. Bezold, and Ms. Arikan are employed by the Institute for Alternative Futures (IAF), an independent nonprofit futures institute. IAF has received grants in the past from many health care organizations and pharmaceutical industry clients for health futures work. None of the 3 authors receive any other compensation from Novo Nordisk; they have no conflict of interest issues to report. Ms. Byrne and Ms. Krohe are employees of Novo Nordisk Inc. They reviewed all drafts of the methodology, the generated diabetes data, and the manuscripts that were developed and written by Dr. Rowley, Dr. Bezold, and Ms. Arikan. They provided their suggestions. The authors received the following financial support for this article: Funding for this study was provided by Novo Nordisk Inc.

Diabetes Care. 2014 Dec;37(12):3137-8. (PMID: 25414386)
MMWR Morb Mortal Wkly Rep. 2014 Nov 21;63(46):1045-9. (PMID: 25412060)
JAMA. 2014 Sep 24;312(12):1218-26. (PMID: 25247518)
Popul Health Metr. 2010 Oct 22;8:29. (PMID: 20969750)
Diabetes Care. 2015 Apr;38(4):581-7. (PMID: 25592194)
Lancet Diabetes Endocrinol. 2014 Nov;2(11):867-74. (PMID: 25128274)
Diabetes Care. 2004 May;27(5):1218-24. (PMID: 15111553)
N Engl J Med. 2013 Apr 25;368(17):1613-24. (PMID: 23614587)
N Engl J Med. 2014 Apr 17;370(16):1514-23. (PMID: 24738668)
Popul Health Manag. 2012 Aug;15(4):194-200. (PMID: 22283662)
BMJ. 1998 Sep 12;317(7160):703-13. (PMID: 9732337)
Am J Cardiol. 1995 May 1;75(14):894-903. (PMID: 7732997)
Diabetes Care. 2014 Dec;37(12):3172-9. (PMID: 25414388)
Lancet. 1998 Sep 12;352(9131):837-53. (PMID: 9742976)
Ann Intern Med. 2015 Dec 1;163(11):861-8. (PMID: 26501513)
J Pediatr. 2005 May;146(5):693-700. (PMID: 15870677)
Diabetes Care. 2012 Jun;35(6):1252-7. (PMID: 22619288)
Diabetes Care. 2015 Mar;38(3):482-7. (PMID: 25552418)
Ann Intern Med. 2014 Sep 2;161(5):328-35. (PMID: 25178569)
NCHS Data Brief. 2015 Nov;(219):1-8. (PMID: 26633046)
N Engl J Med. 2003 Jan 30;348(5):383-93. (PMID: 12556541)

Date Created: 20160429 Date Completed: 20180108 Latest Revision: 20231112

20240628

PMC5278808

10.1089/pop.2015.0181

27124621